The purpose of the Eicosanoid Research Foundation (ERF) is to provide a forum for the dissemination of the latest scientific information on bioactive lipids and mediators in health and disease as it relates to cancer, inflammation, and inflammation associated diseases such as cardiovascular, diabetes, psoriasis, and Alzheimer's, nephrology, arthritis and dermatology.
The ERF holds biennial conferences highlighting data from research at the cutting edge of science on the role of lipid mediators in various physiological and pathological processes. During these conferences, new drugs and medications are discussed, data on clinical trials is examined, and scientists interact to enhance their collaborative efforts. The goal of this meeting series is to promote the exchange of ideas between scientists of diverse backgrounds from around the world. The sole purpose of the ERF is to raise funds to sponsor the International Conference on Bioactive Lipids in Cancer, Inflammation, and Related Diseases, the oldest consecutive international bioactive lipids meeting, thereby promoting continuing advances in this area of science and medical research.
Having held its first forum in 1989 in Detroit, Michigan, subsequent meetings for this international conference were held around the world in Berlin (1991), Georgetown (1993), Hong Kong (1995), La Jolla (1997), Boston (1999), Nashville (2001), Chicago (2003), San Francisco (2005), Montreal (2007), Cancun (2009), Seattle (2011), San Juan, Puerto Rico (2013), Budapest, Hungary (2015), Puerto Vallarta, Mexico (2017), St. Petersburg, FL (2019) with the next meeting planned in Dublin, Ireland (2021).
The Eicosanoid Research Foundation is a non-profit organization funded from pharmaceutical sponsorships, foundation grants, conference exhibitors, advertisers, and registration fees from conference attendees. All funds raised are allocated to the promotion of this international conference series. The ERF is entirely devoted to providing a forum in which to discuss scientific advances in lipid research.